06 Aug, EOD - Indian

Nifty Bank 55411.15 (0.09)

Nifty IT 34426.25 (-1.74)

Nifty Pharma 21523.75 (-2.03)

Nifty Midcap 100 56749.75 (-0.80)

Nifty Smallcap 100 17662.6 (-1.13)

Nifty 50 24574.2 (-0.31)

SENSEX 80543.99 (-0.21)

Nifty Next 50 66181.35 (-0.87)

06 Aug, EOD - Global

NIKKEI 225 40794.86 (0.60)

HANG SENG 24910.63 (0.03)

S&P 6394 (0.90)

LOGIN HERE

flagDai-ichi Karkaria Ltd

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : 526821 | NSE Symbol : DAICHIKARK | ISIN : INE928C01010 | Industry : Chemicals |


Company History

Dai-Ichi Karkaria Limited (DIK) was incorporated on 13 May 1960. The Company is engaged in manufacturing of specialty chemicals. The manufacturing activities of the Company are carried out from plants located at Dahej (Gujarat) and Kurkumbh (Maharashtra). The Company manufactures speciality chemicals has a tie-up with Matsumoto to manufacture spin finishes, which are used for imparting lubrication and anti-static properties to textile filaments and yarns. It is now expanding its production capacity from 750 tpa to 3000 tpa.

DIK had set up a unit to manufacture certain bulk drugs omeprazole, menadione and calcium pentothenate, the last two will be manufactured in India for the first time. DIK is also setting up a unit to manufacture 600 tpa of polyacrylamide-based flocculents which are used for solid-liquid separation.

The expansion cum Diversification plan for High Molecular Weight Flocculants Project at Kurkumbh has been successfully completed. Company had joint venture with project consultant for effluent treatment plants for increasing business.

Company Bulk Drugs & Fine Chemical Projects for patented molecule processes were developed and were scaled up to commercial level by March-99. Company plans to start development of three new products in the pilot facility which is being upgraded presently to meet strict cGMP condition. Company also negotiating with foreign customer for product specific tie-ups in future. Company Spin fishes continue to do well & POY DTY finish has been accepted in the market & company hopes to get orders from leading synthetic fibre manufacturers.

During the year 1999-2000, the company's successfully introduced eight new products in therapeutic areas of cardiovascular, antihistaminics, analgesics, anxiolytic, antidepressant and anticonsulgants.

The Company introduced Emulsifier for Aqua flowables in pesticide formulations during 2001-02. The Pharmaceuticals business was transferred to Inogent Laboratories Pvt. Ltd., a Joint Venture with GVK Bio and Dai-ichi Karkaria Ltd., in October 2005.

During the year 2010-11, the Company had formed a joint venture with CTI Chemicals Asia Pacific Pte. Ltd. (Subsidiary of Champion Technologies Inc.) and its wholly owned subsidiary Basic Oil Treating (India) Ltd. Through the formation of a Joint venture, the shareholding of Champion Dai-ichi Technologies India Ltd. was held by the Company and CTI Chemicals Asia Pacific Pte. Ltd. in the ratio of 50:50. Accordingly Champion Dai-ichi Technologies India Ltd. ceased to be a subsidiary of the Company w.e.f. 7th September, 2010.

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +